Bernd Saletu

Q: What Schools Are Affiliated With Bernd Saletu

Bernd Saletu is affiliated with the following schools: Medical University of Vienna, University of Vienna

Bernd Saletu's AcademicInfluence.com Rankings

Bernd Saletu

Philosophy

#7593

World Rank

#10829

Historical Rank

Logic

#4642

World Rank

#5959

Historical Rank

philosophy Degrees

Bernd Saletu

Biology

#10266

World Rank

#13577

Historical Rank

Neuroscience

#1577

World Rank

#1628

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Bernd Saletu's Degrees

Doctorate Medicine University of Vienna
PhD Psychiatry University of Vienna

Why Is Bernd Saletu Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernd Saletu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy (2012) (934)
Assessing interactions in the brain with exact low-resolution electromagnetic tomography (2011) (602)
Sleep spindles and their significance for declarative memory consolidation. (2004) (531)
Interrater reliability for sleep scoring according to the Rechtschaffen & Kales and the new AASM standard (2009) (304)
Sleep classification according to AASM and Rechtschaffen & Kales: effects on sleep scoring parameters. (2009) (285)
Sleep spindle‐related activity in the human EEG and its relation to general cognitive and learning abilities (2006) (260)
An E-Health Solution for Automatic Sleep Classification according to Rechtschaffen and Kales: Validation Study of the Somnolyzer 24 × 7 Utilizing the Siesta Database (2005) (259)
Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudes. (1996) (247)
Sleep and quality of life in the Austrian population (2000) (246)
Low-resolution brain electromagnetic tomography revealed simultaneously active frontal and parietal sleep spindle sources in the human cortex (2001) (223)
Depression and quality of life in multiple sclerosis (2001) (205)
Topographic distribution of sleep spindles in young healthy subjects (1997) (202)
The SIESTA project polygraphic and clinical database (2001) (172)
EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra. (1972) (170)
Artifact Processing in Computerized Analysis of Sleep EEG – A Review (1999) (154)
Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome (2003) (149)
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) Acute placebo-controlled sleep laboratory studies with clonazepam (2001) (140)
Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA). (1998) (128)
Insomnia in depression: Differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone (2002) (124)
Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial (2012) (123)
Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging). (1987) (123)
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. (2002) (119)
Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography (2004) (119)
Austrian Dream Behavior: Results of a Representative Population Survey (1998) (115)
Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. (1997) (114)
Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. (2008) (113)
Automatic Sleep-Spindle Detection Procedure: Aspects of Reliability and Validity (1994) (110)
On the Pharmacotherapy of Sleep Bruxism: Placebo-Controlled Polysomnographic and Psychometric Studies with Clonazepam (2005) (106)
Treatment of idiopathic restless legs syndrome (RLS) with gabapentin (2001) (105)
Artifact processing in topographic mapping of electroencephalographie activity in neuropsychopharmacology (1992) (103)
Computer-Assisted Sleep Classification according to the Standard of the American Academy of Sleep Medicine: Validation Study of the AASM Version of the Somnolyzer 24 × 7 (2010) (99)
EEG Topography and Tomography (LORETA) in Diagnosis and Pharmacotherapy of Depression (2010) (98)
Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA) (2006) (98)
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study. (2010) (97)
Sleep Laboratory Studies in Restless Legs Syndrome Patients as Compared with Normals and Acute Effects of Ropinirole (2000) (97)
Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. (1991) (96)
Topographic brain mapping of EEG in neuropsychopharmacology--Part I. Methodological aspects. (1987) (94)
Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women (1993) (92)
Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mapping. (2004) (91)
EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. (2002) (91)
Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double‐blind, placebo‐controlled investigations on the effects of a novel estrogen–progestogen combination (Climodien®, Lafamme®) versus est (2003) (85)
Double-blind, Placebo-controlled Psychometric Studies on the Effects of a Combined Estrogen-progestin Regimen versus Estrogen Alone on Performance, Mood and Personality of Menopausal Syndrome Patients (2001) (84)
Discrimination between demented patients and normals based on topographic EEG slow wave activity: comparison between z statistics, discriminant analysis and artificial neural network classifiers. (1994) (84)
Sleep laboratory investigations on hypnotic properties of melatonin (2005) (83)
Memory Dysfunction and Vigilance: Neurophysiological and Psychopharmacological Aspects (1985) (82)
Non-invasive localization of P300 sources in normal aging and age-associated memory impairment (2003) (80)
Sleep Laboratory Studies in Restless Legs Syndrome Patients as Compared with Normals and Acute Effects of Ropinirole (2000) (79)
Auditory evoked response, EEG, and thought process in schizophrenics. (1971) (78)
Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome (2002) (78)
Effects of Selective Serotonin Reuptake Inhibitors on Objective and Subjective Sleep Quality (2000) (77)
EEG Brain Mapping in Diagnostic and Therapeutic Assessment of Dementia (1991) (77)
EEG Topography and Tomography (LORETA) in the Classification and Evaluation of the Pharmacodynamics of Psychotropic Drugs (2006) (76)
Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA). (2002) (76)
Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. (1996) (75)
Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers. (1989) (73)
EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms Comparative studies with remoxipride/haloperidol (1990) (72)
Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression (1995) (71)
Relationship between Depression, Anxiety and Quality of Life: A Study of Stroke Patients Compared to Chronic Low Back Pain and Myocardial Ischemia Patients (2001) (70)
COMPUTERIZED EEC: PREDICTOR OF OUTCOME IN SCHIZOPHRENIA (1975) (68)
Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine. (1994) (67)
Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment (2000) (66)
EEG mapping in patients with social phobia (2004) (65)
Percentile reference charts for selected sleep parameters for 20- to 80-Year-Old healthy subjects from the SIESTA database (2005) (65)
Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA) (2000) (64)
Computer EEG and auditory evoked potential investigations in children at high risk for schizophrenia. (1974) (64)
Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome (2003) (64)
Electrical Sources of P300 Event-Related Brain Potentials Revealed by Low Resolution Electromagnetic Tomography (1997) (62)
Insomnia Related to Dysthymia: Polysomnographic and Psychometric Comparison with Normal Controls and Acute Therapeutic Trials with Trazodone (2001) (62)
PHARMACODYNAMICS OF VENLAFAXINE EVALUATED BY EEG BRAIN MAPPING, PSYCHOMETRY AND PSYCHOPHYSIOLOGY. (1992) (62)
Light Treatment in Depressive Illness (1986) (61)
Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo (2010) (60)
Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine. (1983) (59)
Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses. (1985) (58)
Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. A double-blind comparison with electroconvulsive treatment. (1995) (54)
Studies with lucid dreaming as add‐on therapy to Gestalt therapy (2015) (53)
EEG mapping in patients with restless legs syndrome as compared with normal controls (2002) (53)
Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects. (1988) (53)
P300 event-related potentials and cognitive function in social phobia (2004) (53)
Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs. (2002) (51)
Scalp Topography of the Spontaneous K-Complex and of Delta-Waves in Human Sleep (2004) (51)
Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment. (1995) (50)
Consensus conference on the methodology of clinical trials of antidepressants, Zurich, march 1988: report of the consensus committee (1989) (48)
Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). (1994) (47)
Brain Regions Activated during an Auditory Discrimination Task in Insomniac Postmenopausal Patients before and after Hormone Replacement Therapy: Low-Resolution Brain Electromagnetic Tomography Applied to Event-Related Potentials (2004) (46)
The effect of biologically-active light on the noo- and thymopsyche and on psychophysiological variables in healthy volunteers. (1993) (46)
Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry. (1987) (45)
Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study (1995) (45)
Sleeping habits in the Austrian population. (2002) (44)
Confirmation of the Neurophysiologically Predicted Therapeutic Effects of Trazodone on Its Target Symptoms Depression, Anxiety and Insomnia by Postmarketing Clinical Studies with a Controlled-Release Formulation in Depressed Outpatients (2003) (44)
Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole (2001) (44)
EEG Mapping and psychopharmacological studies with denbufylline in SDAT and MID (1992) (43)
EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug. (1989) (43)
On central effects of serotonin re-uptake inhibitors: Quantitative EEG and psychometric studies with sertraline and zimelidine (2005) (43)
EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil (2004) (43)
Effect of rest on physicians’ performance in an emergency department, objectified by electroencephalographic analyses and psychometric tests* (2002) (43)
Hypno-analgesia and acupuncture analgesia: a neurophysiological reality? (1975) (43)
Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome (2010) (42)
Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor. (1986) (42)
Stability studies in schizophrenics and normals using computer-analyzed EEG. (1974) (42)
First-night-effects on generalized anxiety disorder (GAD)-based insomnia: laboratory versus home sleep recordings. (1996) (41)
Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID). (1992) (41)
EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle. (2002) (41)
Is the subjectively experienced quality of sleep related to objective sleep parameters? (1975) (41)
Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods. (1997) (40)
Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. (1986) (40)
Decrease of vigilance assessed by EEG-mapping in Type I diabetic patients with history of recurrent severe hypoglycaemia (2000) (38)
Insomnia in Somatoform Pain Disorder: Sleep Laboratory Studies on Differences to Controls and Acute Effects of Trazodone, Evaluated by the Somnolyzer 24 × 7 and the Siesta Database (2005) (38)
The relationships between psychopathology and evoked responses before, during, and after psychotropic drug treatment. (1973) (37)
Quantitative EEG, SPEM, and psychometric studies in schizophrenics before and during differential neuroleptic therapy. (1986) (36)
Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy (2007) (36)
Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo‐controlled trials with alprazolam (2000) (35)
Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children. (1975) (34)
Pharmaco-EEG profiles of typical and atypical antidepressants. (1982) (34)
Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry. (1986) (34)
EEG‐Brain mapping, psychometric and psychophysiological studies on central effects of kavain ‐ a kava plant derivative (1989) (33)
EEG Mapping and Low-Resolution Brain Electromagnetic Tomography (LORETA) in Diagnosis and Therapy of Psychiatric Disorders: Evidence for a Key-Lock Principle (2005) (33)
Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver. (1980) (32)
Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment. (1990) (32)
EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington’s disease (2011) (32)
Acute effects of the novel antidepressant venlafaxine on cognitive event‐related potentials (P300), eye blink rate and mood in young healthy subjects (1993) (32)
Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behaviour in elderlies. (1989) (32)
The hypoxia model in human psychopharmacology: neurophysiological and psychometric studies with aniracetam i.v. (1984) (32)
Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations. (1980) (31)
Acoustical signal properties for cardiac/respiratory activity and apneas (2005) (31)
Comparative EEG mapping studies in Huntington’s disease patients and controls (2010) (31)
Home Sleep Apnea Testing is a Feasible and Accurate Method to Diagnose Obstructive Sleep Apnea in Stroke Patients During In-Hospital Rehabilitation. (2018) (31)
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia (2003) (30)
Effects of socio‐demographic variables on health‐related quality of life determined by the quality of life index—German version (2005) (30)
[Epidemiology of sleep disorders in Austria]. (1994) (30)
Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography). (2002) (30)
Digital-computer-analyzed all-night sleep EEG patterns (sleep prints) in schizophrenics. (1972) (29)
Efficiency of Continuous Positive Airway Pressure versus Theophylline Therapy in Sleep Apnea: Comparative Sleep Laboratory Studies on Objective and Subjective Sleep and Awakening Quality (1999) (29)
Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (adrafinil) in elderlies. (1986) (29)
International Pharmaco-EEG group (IPEG). Recommendations for EEG and evoked potential mapping. (1989) (29)
Sleep habits and sleep complaints in Austria: current self‐reported data on sleep behaviour, sleep disturbances and their treatment (2010) (29)
Electrical Sources of P300 Event-Related Brain Potentials Revealed by Low Resolution Electromagnetic Tomography (1997) (29)
Late breaking abstracts (2007) (28)
Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation. (1993) (28)
Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry (1990) (28)
Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life. (1985) (27)
Technetium-99m-HMPAO SPECT imaging of cerebral blood flow during REM sleep in narcoleptics. (1995) (27)
European Consensus Development Conference on menopause (1996) (27)
Event-related-potential low-resolution brain electromagnetic tomography (ERP-LORETA) suggests decreased energetic resources for cognitive processing in narcolepsy (2008) (27)
Digital Computer Analyzed Awake and Sleep EEG (Sleep Prints) in Predicting the Effects of a Triazolobenzodiazepine (U-31, 889) (1972) (27)
Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies. (1990) (27)
Topographic mapping of long latency “cognitive” event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia (1992) (26)
Classification of Psychotropic Drugs Based on Human Evoked Potentials (1974) (26)
Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man. (1995) (26)
Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations. (1986) (26)
CLINICAL AND QUANTITATIVE EEG CHANGES AT DIFFERENT DOSAGE LEVELS OF FLUPHENAZINE TREATMENT (1971) (26)
Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest. (2003) (25)
Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. (1993) (25)
Placebo-Controlled Sleep Laboratory Studies on the Acute Effects of Zolpidem on Objective and Subjective Sleep and Awakening Quality in Nonorganic Insomnia Related to Neurotic and Stress-Related Disorder (2000) (24)
Cerebral Hypoxic Hypoxidosis: Neurophysiological, Psychometric and Pharmacotherapeutic Aspects (1983) (24)
Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS). (1989) (24)
The evoked potential in pharmacopsychiatry. (1977) (23)
Comparative Bioavailability Studies with a New Mixed-micelles Solution of Diazepam Utilizing Radioreceptor Assay, Psychometry and EEG Brain Mapping (1988) (23)
Light treatment in depressive illness. Polysomnographic, psychometric and neuroendocrinological findings. (1986) (23)
Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA). (2009) (23)
EEG–mapping differences between narcolepsy patients and controls and subsequent double–blind, placebo–controlled studies with modafinil (2005) (23)
Effect of biologically active light and partial sleep deprivation on sleep, awakening and circadian rhythms in normals. (1986) (22)
Effects of a Mandibular Repositioning Appliance on Sleep Structure, Morning Behavior and Clinical Symptomatology in Patients with Snoring and Sleep-Disordered Breathing (2007) (22)
Placebo-controlled trial of the xanthine derivative propentofylline in dementia. (1994) (22)
Sleep microstructure and neurodegeneration as measured by [123I]β-CIT SPECT in treated patients with Parkinson’s disease (2004) (22)
Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects (2004) (22)
Cerebral Function in Hyperthyroid Patients (1984) (22)
Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses. (1979) (22)
Topographic pharmaco‐EEG mapping of increasing doses of buspirone and its comparison with diazepam (1994) (22)
Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II. (1983) (22)
On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia. (1996) (21)
Traffic noise-induced sleep disturbances and their correction by an anxiolytic sedative, OX-373. (1981) (21)
Sleep Disturbances in Somatoform Pain Disorder (2003) (20)
Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and — inhibiting fluvoxamine utilizing EEG mapping and psychometry (2005) (20)
Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients. (2002) (20)
Psychophysiological research in psychiatry and neuropsychopharmacology. I. Methodological aspects of the Viennese Psychophysiological Test-System (VPTS). (1989) (20)
Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials. (2005) (20)
Activity monitoring in sleep research, medicine and psychopharmacology. (2001) (20)
Pupillometry in clinical psychophysiological diagnostics: methodology and proposals for application in psychiatry. (1992) (20)
Anxiolytic effects of a new triazolobenzodiazepine, U-31,889. (1973) (20)
[Clinical psychodiagnosis using psychophysiologic procedures]. (1984) (19)
On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies. (1990) (19)
Topographic mapping of EEG during sleep (2005) (19)
Is excessive daytime sleepiness a predictor of carotid atherosclerosis in sleep apnea (2008) (19)
EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials. (1990) (19)
Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG results. (1993) (19)
On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies (1990) (19)
Classification and determination of cerebral biovailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS). (1977) (19)
[Relationship between symptoms of depression and anxiety and the quality of life in multiple sclerosis]. (2001) (19)
Safety of Nicergoline as an Agent for Management of Cognitive Function Disorders (2014) (18)
High prevalence of restless legs syndrome in somatoform pain disorder (2007) (18)
Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics. (1971) (18)
Topographic brain mapping of EEG after acute application of ergotalkaloids in the elderly. (1990) (18)
EEG Imaging of Brain Activity in Clinical Psychopharmacology (1989) (18)
Evaluation of pharmacodynamic properties of psychotropic drugs: quanitative EEG, psychometric and blood level investigations in normals and patients. (1979) (17)
Fluvoxamine—A new serotonin re-uptake inhibitor: First clinical and psychometric experiences in depressed patients (2005) (17)
Sleep quality during alcohol withdrawal with bright light therapy (1997) (17)
The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG. (1982) (17)
Determination of pharmacodynamics of psychotropic drugs by psychometric analysis. (1980) (17)
Effect of tricyclic antidepressants on the Somatosensory evoked potential in man (1973) (17)
Visualizing the Living Human Brain. The Techniques and Promise of EEG and Event-Related Potentials Mapping (1998) (17)
[Street noise and sleep: whole night somnopolygraphic, psychometric and psychophysiologic studies in comparison with normal data]. (1989) (17)
Determination of drug-induced changes in sleep quality based on digital computer "sleep prints". (1974) (17)
Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA) (2005) (16)
Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: electroencephalographic brain mapping and safety evaluation (1988) (16)
Impaired Conditional Discrimination Learning in Social Phobia (2003) (16)
Spontaneous and drug-induced remission of alcoholic organic brain syndrome: Clinical, psychometric, and neurophysiological studies (1983) (16)
Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry. (1984) (16)
Is excessive daytime sleepiness a predictor of carotid atherosclerosis in sleep apnea? (2007) (16)
Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. (1996) (16)
Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry. (1994) (15)
Self reported prevalence and treatment of sleep disorders in Austria. (1995) (15)
Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies. (1984) (15)
Treatment of the alcoholic organic brain syndrome with EMD 21657. A derivative of a pyritinolmetabolite: double-blind clinical, quantitative EEG and psychometric studies. (1978) (15)
[Daytime tiredness correlated with nocturnal respiratory and arousal variables in patients with sleep apnea: polysomnographic and EEG mapping studies]. (2000) (15)
Quantitative EEG: investigation in children with end stage renal disease before and after haemodialysis. (1986) (15)
Digital computer analyzed sleep electroencephalogram (sleep prints) in predicting anxiolytic properties of clorazepate dipotassium (tranxene). (1972) (14)
On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies. (1989) (14)
Effect of minor and major tranquilizers on somatosensory evoked potentials (2004) (14)
Quality of life in nonorganic and organic sleep disorders: I. Comparison with normative data (2003) (14)
Acoustic Evoked Potentials in Offsprings of Schizophrenic Mothers (“High Risk” Children for Schizophrenia) (1975) (14)
Proactive telemedicine monitoring of sleep apnea treatment improves adherence in people with stroke- a randomized controlled trial (HOPES study). (2019) (14)
Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry. (1984) (14)
Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: Quantitative EEG, psychometric and pharmacokinetic studies in man (2005) (14)
Changes in Somatosensory Evoked Potentials during Fluphenazine Treatment (1971) (14)
Quantitative pharmaco-EEG and performance after administration of brotizolam to healthy volunteers. (1983) (14)
Recollection of dreams after short general anaesthesia: influence on patient anxiety and satisfaction (2003) (14)
On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol. (1985) (14)
Sudden arousals from slow wave sleep and panic disorder: successful treatment with anticonvulsants--a case report. (1996) (13)
Effect of Stimulatory Drugs on the Somatosensory Evoked Potential in Man (1972) (13)
Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline. (1997) (13)
Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy. (1984) (12)
CFF and Assessment of Pharmacodynamics: Role and Relationship to Psychometric, EEG and Pharmacokinetic Variables (1982) (12)
Pharmacokinetic and ‐dynamic studies in elderlies with a potential antihypoxidotic/nootropic drug tenilsetam utilizing pharmaco‐EEG and psychometry (1986) (12)
Brain Function Analysis in Childhood Psychosis: Evoked Responses (1975) (12)
A paclitaxel-containing chemotherapy does not cause central nervous adverse effects: a prospective study in patients with ovarian cancer. (2000) (12)
Electrophysiological neuroimaging of the central effects of S-adenosyl-l-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography (2002) (12)
Pharmaco‐EEG, behavioural methods and blood levels in the comparison of temazepam and flunitrazepam (1986) (12)
Fluphenazine treatment in the psychotic child: clinical-evoked potential correlations. (1975) (12)
Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis. (1980) (12)
Proof of antihypoxidotic properties of tenilsetam in man by EEG and psychometric analyses under an experimental hypoxic hypoxidosis (1987) (12)
EEG mapping central effects of multiple doses of linopirine—a cognitive enhancer—in healthy elderly male subjects (1991) (11)
Brain Function during Hypnosis, Acupuncture and Transcendental Meditation (1987) (11)
Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration. (1995) (11)
[Sleep apnea as a risk factor]. (1995) (11)
Objective measures in determining the central effectiveness of a new antihypoxidotic SL-76188: pharmaco-EEG, psychometric and pharmacokinetic analyses in the elderly. (1982) (11)
Confirmation of Pharmaco-EEG Predictions Concerning Pharmacodynamic Properties of an Anxiolytic Sedative by Sleep Studies (1981) (11)
The Effect of Coca-Cola, Caffeine, Antidepressants, and C Chlorpromazine on Objective and Subjective Sleep Parameters (1974) (11)
Cognitions in Sleep: Lucid Dreaming as an Intervention for Nightmares in Patients With Posttraumatic Stress Disorder (2020) (11)
Assessment of psychoactivity and pharmacodynamics of a cerebral vasodilating hexobendine-combination by quantitative electroencephalographic and psychometric analyses (1978) (11)
Neurophysiological aspects of aging and gerontopsychopharmacology. (1989) (10)
Clinical, toxicological and electroencephalographic study with SCH-12,679 in chronic schizophrenics. (1971) (10)
Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: psychometric and psychophysiological data (1988) (10)
Determination of Pharmacokinetics and Pharmacodynamics of Amisulpride by Pharmaco-EEG and Psychometry (1985) (10)
Evoked responses after hemispherectomy. (1971) (10)
Assessment of Pharmacodynamics of a New “Controlled-Release” Form of Diazepam (Valium® CR Roche) by Quantitative EEG and Psychometric Analysis in Neurotic Subjects (1981) (10)
Topographic brain mapping of EEG before and after open-heart surgery. (1988) (10)
Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I. (1983) (10)
Classification of Psychotropic Drugs Based on Digital Computer Sleep Prints1 (1974) (9)
Drawing Inferences about the Therapeutic Efficacy of Drugs in Patients from their CNS Effect in Normals: Comparative Quantitative Pharmaco-EEG and Clinical Investigations (1979) (9)
[Pupillometry in psychopharmacologic experiments]. (1986) (9)
Classification and Assessment of Pharmacodynamics of SGD-SCHA1059 (Binodaline) by Quantitative EEG and Psychometric Analyses (1980) (9)
Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys. (1974) (9)
Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography. (2002) (9)
Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise. (1987) (9)
Anxiolytics and beta blockers: evaluation of pharmacodynamics by quantitative EEG, psychometric and physiological variables. (1981) (9)
Non-invasive electrophysiological neuroimaging of sleep (2002) (9)
Changes in clinical symptomatology and psychometric assessments in depressed patients during mianserin and combined amitriptyline/ chlordiazepoxide therapy: a double-blind comparison (1980) (9)
K-complex amplitude as a marker of sleep homeostasis in obstructive sleep apnea syndrome and healthy controls (2015) (8)
The key-lock principle in the diagnosis and treatment of nonorganic insomnia related to psychiatric disorders: sleep laboratory investigations. (2002) (8)
EEG brain mapping in gerontopsychopharmacology: On protective properties of pyritinol against hypoxic hypoxidosis (1989) (8)
Amantadine infusions in mild dementia: acute double-blind placebo-controlled EEG mapping and psychometric studies. (1992) (8)
Quantitative EEG Changes during Thiothixene Treatment of Chronic Schizophrenics (1972) (8)
Tandamine--a new norepinephrine reuptake inhibitor. Clinical, psychometric and quantitative EEG studies in depressed patients. (1977) (8)
Nocturnal Traffic Noise, Sleep, and Quality of Awakening: Neurophysiologic, Psychometric, and Receptor Activity Changes after Quazepam (1985) (8)
Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry (2005) (8)
Involvement of sleep spindles in overnight declarative memory stabilization (2015) (7)
Double‐blind, placebo‐controlled, multiple‐ascending‐dose study on the effects of ABIO‐08/01, a novel anxiolytic drug, on perception and cognition, utilizing event‐related potential mapping and low‐resolution brain electromagnetic tomography (2008) (7)
Early clinical pharmacological studies with sercloremine—a novel antidepressant—utilizing pharmacokinetic, pharmaco‐EEG, and psychometric analyses (1985) (7)
Correlation Maps: On the Relation of Electroencephalographic Slow Wave Activity to Computerized Tomography and Psychopathometric Measurements in Dementia (1993) (7)
Thiothixene in childhood psychoses. (1974) (7)
[Dynamic light-evoked pupillometry for the differentiation of psychotropic substances]. (1987) (7)
Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry (2002) (7)
Sleep and memory consolidation: The role of electrophysiological neuroimaging (2002) (7)
Prediction of neuroleptic effects of CI-686 based on quantitative pharmaco-electroencephalography: drug profiles and dose response curves based on computerized cerebral bio-potentials. (1974) (7)
Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations. (1973) (7)
Recent advances in the clinical pharmacology of benzodiazepines part I: Pharmacokinetics (1987) (7)
Erratum to: Dysfunctional pain modulation in somatoform pain disorder patients (2011) (7)
Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364. (1987) (7)
Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: psychometric and psychophysiological evaluation. (1993) (7)
Effects of fluphenazine hydrochloride on digital computer sleep prints of schizophrenic patients. (1971) (6)
Dysfunctional pain modulation in somatoform pain disorder patients. (2011) (6)
Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil). (1988) (6)
EXPERIMENTALLY-INDUCED HYPOXIC HYPOXIDOSIS IN HUMAN GERONTO-PSYCHOPHARMACOLOGY: PHARMACO-EEG AND PSYCHOMETERIC STUDIES (1984) (6)
[Nightly television and sleep. Polysomnographic, psychometric and psychopharmacologic studies of patients with sleep disorders]. (1983) (6)
Sleep laboratory studies on single dose effects of suriclone. (1990) (6)
Home polygraphic recording with telemedicine monitoring for diagnosis and treatment of sleep apnoea in stroke (HOPES Study): study protocol for a single-blind, randomised controlled trial (2018) (6)
Topographic EEG Brain Maps and Mental Performance Under Hypoxia After Placebo and Pyritinol (1989) (6)
Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations. (1976) (6)
Procedural memory consolidation is associated with heart rate variability and sleep spindles (2019) (6)
Digital computer-analyzed resting and sleep EEGs (sleep prints) after hemispherectomy in man. (1971) (6)
Reduced Brain Electric Activity and Functional Connectivity in Bipolar Euthymia: An sLORETA Source Localization Study (2019) (6)
[A new method for measuring central activation: fourier analysis of pupillary oscillations in depressed patients]. (1994) (6)
Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping. (2002) (6)
Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry. (1986) (6)
On the central effects of the GABA agonist fengabine: Psychometric and pharmaco‐EEG studies utilizing imaging methods (1987) (6)
The effect of DMT and LSD on acoustic evoked potentials. (1971) (5)
Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia. (1996) (5)
[Determination of the encephalotropic, psychotropic and pharmacodynamic properties of nicergoline by means of quantitative pharmacoelectroencephalography and psychometric analysis]. (1979) (5)
[Computer-assisted determination of rigidity in the differentiation of psychopathologic groups]. (1988) (5)
[Objective assessment and therapeutic efficacy of an improved mandibular advancement device for snoring and sleep apnea syndromes with polysomnography]. (2002) (5)
Somatosensory evoked potential: an objective indicator of the therapy efficacy of a new psychotropic drug, clorazepate dipotassium (tranxene). (1972) (5)
Digital Computer “Sleep Prints” — an Indicator of the Most Effective Drug Treatment of Somnambulism (1973) (5)
Theophylline in snoring and sleep-related breathing disorders: sleep laboratory investigations on subjective and objective sleep and awakening quality. (2000) (5)
[Sleep disorders in psychiatry and their treatment]. (2013) (5)
Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients. (1983) (5)
Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: a prospective EEG mapping study in 28 patients. (2001) (5)
The Acute Drug Effect as Predictor of Therapeutic Outcome: Neurophysiological/ Behavioral Correlations during Anxiolytic Therapy of Alcoholics (1982) (5)
[Anxiety and anger: psychobiologic studies on the question of the specific anxiolytic effect of tranquilizers]. (1984) (5)
[Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)]. (1984) (4)
[Evening television and sleep. Polysomnographic, psychometric and psychopharmacologic studies in sleep disordered patients (II)]. (1983) (4)
Sleep laboratory study of a new antianxiety drug, alpidem: short-term trial (1986) (4)
[Neurophysiologic methods in psychopharmacology]. (1973) (4)
All-Night Sleep in Relation to Awake Brain Activity (1974) (4)
[Nonorganic hypersomnia: epidemiology, diagnosis, and therapy]. (2001) (4)
Recent advances in sleep research. (2013) (4)
[Use of a microcomputer for routine studies and research in the field of clinical psychodiagnosis]. (1984) (4)
Subject Index Vol. 24, 1991 (1990) (4)
Examining Pharmaco EEG-Based Predictions about the Antidepressant Action of Pirlindol by Double Blind Clinical Trials (1985) (4)
Topographical and source analysis of the P300 event-related brain potential in normal aging and in age-associated memory impairment before and after Ginkgo biloba therapy (1996) (4)
Somatosensory evoked potential changes during thiothixene treatment in schizophrenic patients (2004) (4)
BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. (1994) (4)
[The pupillary response test as a method to differentiate various types of dementia]. (2009) (3)
[Repolarisation disturbances in the ECG under antidepressant drugs. A comparison of two drugs, differing in chemical structure and pharmacological profile (author's transl)]. (1979) (3)
Daytime noopsychic and thymopsychia dysfunctions in monorganic insomnia related to different mental disorders (2002) (3)
Are hormones psychoactive? Evoked potential investigations in man. (1975) (3)
Obstructive sleep apnea: a polysomnographic study of sleep apnea before and after tonsillectomy and adenoidectomy. (1988) (3)
Testing Drugs for Impaired Brain Function in Old Age: On the Effects of a Single Dose of Bifemelane using Topographic Mapping of EEG and Event‐Related Potentials (P300) and Psychometric Measurements in Healthy Elderly Subjects (1996) (3)
Intensive antidepressive therapy by 48 hour slow-drip infusion with high doses dibenzepine. (1977) (3)
[Computer-assisted static and light-evoked dynamic pupillometry in psychosomatic patients]. (1985) (3)
Acute and sub-acute, double-blind, placebo-controlled studies on the effects of S-adenosyl-l-methionine on information processing by ERP-mapping and LORETA (2002) (3)
Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder. (1997) (3)
[Treatment of negative symptoms in schizophrenia with neuroleptics]. (1989) (3)
Differential effects of fast and slow sleep spindles in early and late sleep on the consolidation of an explicit memory task (2006) (3)
Nocturnal traffic noise and sleep / effects and countereffects by oxazolam. (1980) (3)
Quality of life in nonorganic and organic sleep disorders: II. Correlation with objective and subjective quality of sleep and awakening (2003) (3)
Clinical, brain mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine (1991) (2)
Clinical, toxicological and electroencephalographical effects of a new tricyclic antidepressant, OI-77. (1972) (2)
Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity (2009) (2)
[Effect of nootropic drugs on normal and disturbed sleep of the elderly: controlled studies with pyridoxilate and street noise]. (1984) (2)
EVALUATION OF ACOUSTIC SIGNALS FOR THE DETECTION OF SLEEP APNEA EVENTS (2000) (2)
[Assessment of psychoactivity and long-term efficacy of a retard preparation of oxazepam by blood level determinations and quantitative eeg and psychometric analyses (author's transl)]. (1978) (2)
[Duration of spiral after-effects in psychosomatic patients (a psychophysiologic study and analysis of data using multivariate procedures)]. (1984) (2)
Low-resolution brain electromagnetic tomography reveals local neural reactivation during spindle episodes in the night following paired word associate learning (2005) (2)
EEG mapping and tomography providing evidence for a key-lock principle in diagnosis and treatment of mental disorders (2002) (2)
Neurophysiology and Child Psychiatry (1979) (2)
Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity (2009) (2)
On the Value of CNS, ANS and Behavioral Measures in Early Clinical Psychopharmacology (1985) (2)
The treatment of endomorphous and psychogenic depressions with a fixed combination of amitriptyline/flupenthixol (Lu 7410). (1976) (2)
[Fatigue and stress sensitivity of physicians after 16 hours on duty at the emergency department]. (2001) (2)
[Quantitative neurophysiological aspects in schizophrenia prior to and during psychopharmacotherapy (author's transl)]. (1978) (2)
Effect-kinetics on brain protection of two codergocrine-mesylate preparations (Aramexe retard and Hydergine) by EEG mapping and psychometry under hypoxia. (1994) (2)
Insomnia During Menopause (2006) (2)
22-2 QEEG and drug evaluation in psychopharmacology (1997) (2)
Paclitaxel does not cause central nervous adverse effects: a prospective vigilance-controlled EEG mapping study in ovarian cancer patients. (2000) (2)
P.1.c.031 Effect of almorexant treatment on sleep variables in patients with primary insomnia compared with healthy controls (2010) (2)
[Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules]. (1987) (2)
[Factor analytic study and determination of rehabilitation of static and dynamic pupillometry in normal persons and psychopathologic groups]. (1987) (2)
[Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine]. (1991) (2)
S.26.04 EEG/ERP-mapping as a tool in psychopharmacology (1997) (2)
[Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry]. (1983) (2)
Thiopental Activation and Spontaneous Sleep and Dream Patterns of Resistant Schizophrenics * (1972) (2)
[Proceedings: Psychotropic drugs and quality of sleep: quantitative neurophysiological and subjective parameters (author's transl)]. (1976) (2)
[Psychotropic drugs, brain function and sleep. Neurophysiologic aspects of psychopharmacology and pharmacopsychiatry]. (1976) (2)
Neuroimaging of Sleep and Sleep Disorders: Fundamentals of low-resolution brain electromagnetic tomography (2013) (2)
Accelerated remission of the alcoholic organic brain syndrome with EMD 21657. Double-blind clinical and psychometric trials. (1978) (1)
P-8-3 Sleep studies in insomnia based on generalized anxiety disorder with diphenhydramine/lorazepam (SomniumR) (1996) (1)
On the Cerebro-Protective Effects of Caroverine: Double-Blind, Placebo-Controlled, EEG Mapping and Psychometric Studies under Hypoxia (1998) (1)
EEG MAPPING IN DEMENTIA AND NOOTROPIC DRUG RESEARCH (1992) (1)
RECENT ADVANCES IN SLEEP RESEARCH NEUE ERKENNTNISSE IN DER SCHLAFFORSCHUNG (2013) (1)
Slow-drip dibenzepine infusion in depression. Proof of rapid efficacy by quantitative EEG and affect-polarity profile studies. (1976) (1)
WS5-1 Drug effects on EEG topography and tomography (2010) (1)
Modern problems of pharmacopsychiatry, Vol. 8: Psychotropic drugs and the human EEG (1975) (1)
Clinical and EEG investigations with CI-579 and CI-600 (quantitative pharmacoelectroencephalography and "sleep prints"). (1973) (1)
Central Effects of Acute, Intravenous and Oral Caroverine in Man: Double-Blind, Placebo-Controlled EEG Mapping and Psychometry (1998) (1)
The Psychopharmacology and Neuroendocrinology of Neuroleptics: The State of the Art from a Clinical Perspective (1986) (1)
Classification and determination of cerebral bioavailability of suriclone based on EEG brain mapping and psychometry (1991) (1)
Measurement of CNS Effects (2020) (1)
Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry (2005) (1)
Neuro-psychopharmacology: Proceedings of the 11th congress of the Collegium Internationale Neuro-psychopharmacologium, Vienna, July 9-14, 1978 (1979) (1)
[Sleep disorders in neurology. Hypersomnia]. (1997) (1)
19th biennial IPEG Meeting (2016) (1)
[Influence of the disco-scene on the psyche and soma of young people: psychometric, computerized-EEG and physiological studies (author's transl)]. (1982) (1)
On the central effects of increasing doses of buspirone: a pharmaco-EEG study utilizing imaging methods (1991) (1)
FC12-06 - On the relevance of comorbidity in psychiatry: EEG loreta in generalized anxiety disorder with and without nonorganic Insomnia (2011) (1)
[Hyperthyroidism-induced endocrine psychosyndrome]. (1983) (1)
Subject Index Vol. 48, 2003 (2003) (1)
Comparative sleep laboratory evaluations of quazepam and triazolam in hyposomnic patients with mild to moderate generalized anxiety disorder (1992) (1)
[Computer-assisted static and dynamic pupillometry for the characterization of tricyclic antidepressive agent, cianopramine]. (1988) (1)
Subject Index Vol. 25, Suppl 2, 1986 (1986) (0)
Subject Index Vol. 7, 1981 (1981) (0)
Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry ∗E. Paulus, B. Saletu, J. Grünberger, L. Linzmayer and P. Anderer. Department of Pharmacopsychiatry, Psychiatric University Clinic of Vienna, Austria (1990) (0)
P0015 Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy (2007) (0)
COMPARISON OF POSTTREATMENT‐EEG IN ELECTROCONVULSIVE THERAPY AND ISOFLURAN‐NARCOTHERAPY IN DEPRESSIVE PATIENTS (1992) (0)
Neurophysiological Aspects of Gerontopsychopharmacotherapy (1985) (0)
[Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination]. (1985) (0)
Subject Index Vol. 55, 2007 (2007) (0)
Is level III polygraphy a feasible and valid method to diagnose OSA in stroke patients (2017) (0)
Selfreported prevalence andtreatment ofsleep disorders in (1995) (0)
Subjective versus objective sleep quality in insomnia based on generalized anxiety disorder: 7.2 (1995) (0)
Contents Vol. 66, 2012 (2012) (0)
In Memory of Antonio Arrigo, MD (1929–1990) (1990) (0)
P167 Clinical and psychometric studies in menopausal syndrome patients with and without depression (1996) (0)
[CNS- and psycho-activity of the anorectic drugs Phentermine and Fenfluramine: Blood level, quantitative EEG and psychometric analyses (author's transl)]. (1977) (0)
PAP adherence of stroke patients with obstructive sleep apnea after a novel treatment strategie during in-hospital rehabilitation (2017) (0)
P.4.b.006 Objective versus subjective sleep efficiency in apnea and insomnia patients due to generalised anxiety disorder as compared with normals (2013) (0)
Subject Index Vol. 36, 2003 (2003) (0)
The new generation of selective monoamine oxidase-inhibitors: biochemical, pharmacological and clinical perspectives. (1988) (0)
Quantitative electrophysiology during night- and daytime including electroencephalography and event-related potential EEG/ERP topography and tomography (LORETA) in hyperthyroidism (2011) (0)
8 th World Congress of the International Society for Brain Electromagnetic Topography ( ISBET ) with The KEY Foundation Symposium " Brain Fields in Psychiatry " Zurich , Switzerland , March 6-8 , 1997 (2019) (0)
Contents Vol. 55, 2007 (2007) (0)
Differential Diagnosis of Insomnia (2010) (0)
P03.442 Impaired conditional discrimination learning in patients with social phobia (2000) (0)
Contents Vol. 51, 2005 (2005) (0)
Contents, Vol. 19, Supplement 2, 1986 (1986) (0)
Assessment of Pharmacodynamics ofa New "Controlled Release" Form of Diazepam (Valium (1981) (0)
Contents, Vol. 7, 1981 (1981) (0)
P0103 Comparative polysomnographic and psychometric studies on the acute effects of gabapentin and ropinirol in the treatment of restless legs syndrome (2007) (0)
[Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients]. (1993) (0)
S-35-2 Estrogen in postmenopausal women with and without depression: EEG, endocrinological and psychometric studies (1996) (0)
Low-dose amisulpride: some evidence for alertness-increasing properties in EEG studies (2000) (0)
Sleep and its significance for memory consolidation (2003) (0)
Subject Index Vol. 41, 2000 (2000) (0)
Cardiac phobia, central and autonomous nervous system: psychological and polygraphic studies under music (1984) (0)
CS03-03 - Sleep and sleep disorders in somatoform pain disorder (2011) (0)
Neurophysiological Aspects of Positive and Negative Schizophrenia and Therapeutic Consequences: Trials with Benzamides (1998) (0)
P.l.c.057 Effects of trazodone on sleep, respiratory and nocturnal movement variables in insomniac somatoform pain patients (2009) (0)
Influence of a Combined Estrogen-progestin Regimen (Klimodien) versus Estrogen Alone on Sleep Disorders, Vigilance and Cognition: A Double-blind, Placebo-controlled Study: P-97. (1999) (0)
Contents Vol. 36, 2003 (2003) (0)
8th World Congress of the International Society for Brain Electromagnetic Topography (ISBET) with The KEY Foundation Symposium “Brain Fields in Psychiatry” (2004) (0)
FC07-04 - Electrophysiological neuroimaging reveals re-set, re-activation and re-processing of procedural and declarative memory traces during post-training sleep (2011) (0)
PS-62-6 EEG mapping in generalized anxiety disorder (1995) (0)
Professor Manuel José Barbanoj Rodriguez (2012) (0)
Dissociation between pharmaco-EEG changes and vigilance assessments Phase I study with a racemic compound (2002) (0)
Topographic brain mapping of EEG after ergotalkaloids in elderlies (1989) (0)
[Sleep disorders in neurology: hyposomnia]. (1993) (0)
L-11 Quantitatively analyzed EEG/EEG mapping in diagnosis and treatment of dementias (1995) (0)
Contents Vol. 62, 2010 (2010) (0)
Discussion to “Stress and the brain” by Isabella Heuser and Claas-Hinrich Lammers and “Stress and aging: theoretical and empirical challenges for interdisciplinary research” by Jacqui Smith (2003) (0)
Cardiac Phobia, Central and Autonomous Nervous System (1984) (0)
On the positive - negative distinction of schizophrenia: C orrelations between psychopathology and EEG brain mapping (1990) (0)
L0051 Evaluating sleep stages and events in a normative database of good sleep (2007) (0)
Contents Vol. 48, 2003 (2003) (0)
14-14 Comparative EEG-mapping and psychometry in insomniac GAD patients with diphenhydramine/lorazepam (SomniumR) (1997) (0)
[Current problems in delusion research]. (1971) (0)
EEG mapping in positive and negative schizophrenia and under different neuroleptics (1998) (0)
Proceedings: Comparative neurophysiological investigation in hypnosis, acupuncture and drug-analgesia. (1975) (0)
Slow-Drip Dibenzepine Infusion in Depression (1976) (0)
Pathophysiological relations between panic disorder and sleep terrors: a therapeutic approach with anticonvulsants in a single case (1995) (0)
Subject Index Vol. 51, 2005 (2005) (0)
Estrogen, Vigilance, and Depression in the Menopause: Clinical and EEG Mapping Studies with Es-traderm TTS: P-81. (1995) (0)
Subject Index Vol. 62, 2010 (2010) (0)
Subject Index Vol. 31, 1995 (1995) (0)
Prediction of Drug Treatment Effective in Narcolepsy Based on Digital Computer Analyzed EEG (1971) (0)
Sleep Breathing Disorders – 3 P 242 5 years clinical experience with esophagopharyngeal pressure measurement (0)
EEG‐FLATLINE IN ISOFLURANE‐NARCOTHERAPY: A NEW PARAMETER FOR SEVERITIY OF DEPRESSION? (1992) (0)
[Clinical-psychopathological and electroencephalographic studies on patients with delusions of the paranoic and the paraphrenic types]. (1975) (0)
Poster Presentation: P-73. Clinical and Psychometric Studies in Menopausal Syndrome Patients with and without Depression (1994) (0)
Promoting Vigilance in Older People: Comparative Pharmaco-EEG and Psychometric Studies with Nicergoline by Oral and Intramuscular Administration (1986) (0)
Brain activity related to memory retrieval changes after overnight sleep: a study of EEG theta frequency (2006) (0)
Contents Vol. 41, 2000 (2000) (0)
Professor Werner M. Herrmann (2003) (0)
Insomnia During Menopause: Sleep Laboratory Studies on Insomnia Associated with Postmenopausal Syndrome and Hormone Replacement Therapy (2013) (0)
O-23-3 Central effects of 5HT1A-agonists, S-20499 and buspirone: Placebo-controlled, pharmaco-EEG and psychometric studies (1996) (0)
Recent advances in the clinical pharmacology of benzodiazepines part II: Pharmacodynamics (1987) (0)
Contents, Vol. 24, 1990-91 (1990) (0)
A paclitaxel‐containing chemotherapy in patients with ovarian cancer does not cause encephalopathy: a prospective resting‐EEG (R‐EEG) mapping study in 28 patients (2000) (0)
P01.49 Low dose amisulpride: Some evidence for alertness-increasing properties in EEG studies (2000) (0)
Austrian Sleep and Dream Behavior Questionnaire (2015) (0)
530. Cognitive psychophysiology in anxiolytic drug research (1996) (0)
[Electrodermal activity--"psychovegetative resonance" in AIDS patients]. (1989) (0)
ENDOCRINE PROFILES DURING 60 HOURS ALCOHOL‐WITHDRAWAL IN CHRONIC ALCOHOLICS (1992) (0)
Subject Index Vol. 46, 2002 (2003) (0)
[A new method for testing the psychopharmacologic pupil oscillation hypothesis following administration of a nootropic substance]. (1995) (0)
309 Influence of an afternoon rest on psychophysiological markers in emergency physicians during prolonged shift work (1998) (0)
Discussion to ‘Imaging methods for evaluating brain function in man’ by Robert M. Kessler (2003) (0)
EEG/ERP topography and tomography in diagnosis and pharmacotherapy of depression: A key-lock principle? (2008) (0)
P-74. EEG/EP Mapping in Menopausal Syndrome with and without Depression (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernd Saletu?

Bernd Saletu is affiliated with the following schools:

Bernd Saletu's Academic­Influence.com Rankings

Bernd Saletu's Degrees

Why Is Bernd Saletu Influential?

Bernd Saletu's Published Works

Published Works

What Schools Are Affiliated With Bernd Saletu?

Bernd Saletu's AcademicInfluence.com Rankings